Home / Stocks / EMSHF

EMSHF (Specialty Chemicals) Stock Valuation & Fair Value Significantly overvalued

EMSHF (Specialty Chemicals) trades at a blended P/E of 38.2, about 35% above its historical normal valuation, with a forward growth estimate of 5.6% and a PEG of 6.87. Analysts' one-year estimates have been hit 64% of the time.

No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation, forecast return and analyst accuracy only. Ratings that cite business quality require one.

DATA AS OF 2026-09-21
Blended P/E
38.2
Normal P/E
28.2
PEG
6.87
Fwd growth
5.6%
Div yield
2.3%
RSI (14)
100.0
Overbought

Valuation flags

Verdict history

tickerseer's rating has been significantly overvalued since 2026-09-19.

Blended P/E and rating by weekBlended P/E moved from 38.2 to 38.2 between 2026-09-19 and 2026-09-21, against a normal P/E of 28.2, with 0 rating changes over 2 recorded weeks.2026-09-19: P/E 38.2, Significantly overvalued (recalculated)2026-09-21: P/E 38.2, Significantly overvalued30.032.535.037.5Sep 19Sep 20Sep 21Normal P/E 28.2
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Ratings recorded live since 2026-09-21. Earlier points apply today's valuation rules to the metrics tickerseer archived that week.

WeekBlended P/EPremium to normal P/ERating
2026-09-19P/E 38.2+35%Significantly overvalued
2026-09-21P/E 38.2+35%Significantly overvalued ← now

Frequently asked questions

Is EMSHF overvalued?

At a blended P/E of 38.2 versus its historical normal P/E of 28.2, EMSHF trades about 35% above its typical valuation, with a PEG of 6.87 on 5.6% forward growth. tickerseer currently rates it significantly overvalued.

What is EMSHF's fair value and PEG?

EMSHF trades at a blended P/E of 38.2 against a historical normal P/E of 28.2, a PEG of 6.87, and a forward growth estimate of 5.6%.

Has tickerseer's rating of EMSHF changed?

tickerseer's rating has been significantly overvalued since 2026-09-19.

Industry: Specialty Chemicals. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track EMSHF free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.